Advances in PSC, NAFLD, and Liver Transplantation for Patients with HCV Infection reported at International Liver Congress

A chemical cousin of an existing drug shows promise for patients with primary sclerosing cholangitis (PSC), a larger waistline increases risk for severe nonalcoholic fatty liver disease (NAFLD), and livers from hepatitis C virus (HCV)-infected donors are safe for transplant into HCV-infected recipients were all among the exciting findings reported

Read more
  • Video: Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Video: Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis

Obeticholic acid significantly reduces biochemical features of primary biliary cirrhosis (PBC) in patients with an inadequate response to ursodeoxycholic acid (UDCA) therapy, Gideon M. Hirschfield et al report in the April issue of Gastroenterology. Hirschfield discusses the details of the study and its findings in a video abstract: PBC is a progressive, autoimmune

Read more